Please Wait

Applying Filters...

Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Oxybuprocaine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 1 USDMF, 1 CEP/COS, 2 JDMF, 2 NDC API, 5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers, 3 FDA Orange Book, 4 Europe, 2 South Africa

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.25%, SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.3%

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 1 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Gangwal Chemicals, 1 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

8 Fillers, Diluents & Binders, 7 Solubilizers, 5 Granulation, 5 Direct Compression, 3 Parenteral, 3 Controlled & Modified Release, 2 Disintegrants & Superdisintegrants, 1 Thickeners and Stabilizers, 1 Topical, 1 Film Formers & Plasticizers, 1 Co-Processed Excipients, 1 Coating Systems & Additives